Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 1,222 shares at $95.60 ($117K) on 2019-07-16, disclosed to the SEC on 2019-07-18.
Open-market sale of $117k BPMC by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |